These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 3486300)

  • 21. [Assessment of regional myocardial blood flow and energy metabolism].
    Yonekura Y; Senda M; Torizuka K
    J Cardiol Suppl; 1987; 15():65-9. PubMed ID: 3509973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-invasive regional assessment of myocardium with positron-emitting radionuclides.
    Sobel BE
    Adv Cardiol; 1979; 26():15-29. PubMed ID: 420059
    [No Abstract]   [Full Text] [Related]  

  • 23. Identification and differentiation of resting myocardial ischemia and infarction in man with positron computed tomography, 18F-labeled fluorodeoxyglucose and N-13 ammonia.
    Marshall RC; Tillisch JH; Phelps ME; Huang SC; Carson R; Henze E; Schelbert HR
    Circulation; 1983 Apr; 67(4):766-78. PubMed ID: 6600659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of regional myocardial ischemia by positron-emission computed tomography.
    Schelbert HR; Henze E; Phelps ME; Kuhl DE
    Am Heart J; 1982 Apr; 103(4 Pt 2):588-97. PubMed ID: 6978056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myocardial imaging with radiolabelled free fatty acids: a critical review.
    van der Wall EE
    Eur Heart J; 1985 Aug; 6 Suppl B():29-38. PubMed ID: 3910439
    [No Abstract]   [Full Text] [Related]  

  • 26. Abnormal myocardial fatty acid metabolism in dilated cardiomyopathy detected by iodine-123 phenylpentadecanoic acid and tomographic imaging.
    Ugolini V; Hansen CL; Kulkarni PV; Jansen DE; Akers MS; Corbett JR
    Am J Cardiol; 1988 Nov; 62(13):923-8. PubMed ID: 3263035
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Positron emission tomography as an aid in understanding electrocardiographic changes of ischemia, infarction, and cardiomyopathy.
    Grover-McKay M
    Ann N Y Acad Sci; 1990; 601():77-94. PubMed ID: 2221703
    [No Abstract]   [Full Text] [Related]  

  • 28. 18F-deoxyglucose and the assessment of myocardial viability.
    Schelbert HR
    Semin Nucl Med; 2002 Jan; 32(1):60-9. PubMed ID: 11839071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Positron emission tomography: the prospects for studying myocardial metabolism in vivo].
    Ashmarin IIu
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1984; 7(2):103-7. PubMed ID: 6391515
    [No Abstract]   [Full Text] [Related]  

  • 30. [Principles and applications of positron emission tomography (PET) in cardiology. PET in Mexico: a reality].
    Alexanderson Rosas E; Kerik NE; Unzek Freiman S; Fermon Schwaycer S
    Arch Cardiol Mex; 2002; 72(2):157-64. PubMed ID: 12148336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Evaluation of myocardial glucose utilization of hypertrophic and dilated cardiomyopathy using 18F-2-fluoro 2-deoxy-D-glucose and positron emission tomography].
    Ohtake T; Kosaka N; Watanabe T; Momose T; Nishikawa J; Sasaki Y; Iio M; Yokoyama I; Iizuka M; Sugimoto T
    Nihon Rinsho; 1991 Jan; 49(1):143-7. PubMed ID: 2002593
    [No Abstract]   [Full Text] [Related]  

  • 32. Assessment of myocardial fatty acid metabolism with positron emission tomography at rest and during dobutamine infusion in patients with coronary artery disease.
    Tamaki N; Kawamoto M; Takahashi N; Yonekura Y; Magata Y; Torizuka T; Nohara R; Kambara H; Konishi J
    Am Heart J; 1993 Mar; 125(3):702-10. PubMed ID: 8438699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relative changes in free-fatty-acid and glucose utilisation by ischaemic myocardium after coronary-artery occlusion.
    Owen P; Thomas M; Opie L
    Lancet; 1969 Jun; 1(7607):1187-90. PubMed ID: 4181841
    [No Abstract]   [Full Text] [Related]  

  • 34. [Radionuclide assessment of myocardial failure: importance of metabolic mapping].
    Nishimura T; Nagata S; Uehara T; Shimonagata T; Miyatake K
    Jpn Circ J; 1992; 56 Suppl 5():1291-3. PubMed ID: 1291711
    [No Abstract]   [Full Text] [Related]  

  • 35. Emission tomography of the heart.
    Schelbert HR; Henze E; Phelps ME
    Semin Nucl Med; 1980 Oct; 10(4):355-73. PubMed ID: 6999625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of myocardial viability with positron emission tomography in a patient with ischemic cardiomyopathy.
    J Nucl Med; 1991 Jan; 32(1):130-5. PubMed ID: 1988617
    [No Abstract]   [Full Text] [Related]  

  • 37. External quantification of myocardial ischemia and infarction with positron-emitting radionuclides.
    Sobel BE
    Adv Cardiol; 1978; (22):29-47. PubMed ID: 619522
    [No Abstract]   [Full Text] [Related]  

  • 38. Regional myocardial perfusion and metabolism assessed by positron emission tomography in children with Kawasaki disease and significance of abnormal Q waves and their disappearance.
    Yoshibayashi M; Tamaki N; Nishioka K; Matsumura M; Ueda T; Temma S; Yonekura Y; Yamashita K; Konishi J; Mikawa H
    Am J Cardiol; 1991 Dec; 68(17):1638-45. PubMed ID: 1746466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estimated glycolytic flux in infarcting heart.
    Opie LH; Owen P; Lubbe W
    Recent Adv Stud Cardiac Struct Metab; 1975; 7():249-55. PubMed ID: 131960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Accumulation of fluorodeoxyglucose in ischemic myocardium. I. Comparison with myocardial perfusion at rest and during exercise].
    Yonekura Y; Senda M; Koide H; Saji H; Yamamoto K; Nishizawa S; Torizuka K; Fudo T; Hashimoto T; Kambara H
    Kaku Igaku; 1986 Oct; 23(10):1361-7. PubMed ID: 3493371
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.